Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Has Consensus Price Target of $493.54 According to Brokerages

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned an average rating of “Moderate Buy” from the thirty brokerages that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, twenty-three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $493.54.

ISRG has been the topic of a number of research reports. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. Wells Fargo & Company reiterated an “overweight” rating and set a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Royal Bank Of Canada reduced their target price on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research note on Wednesday, October 21st. HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a research note on Wednesday, October 21st.

Insider Buying and Selling

In other news, VP Fredrik Widman sold 4,047 shares of the firm’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the sale, the vice president owned 1,026 shares in the company, valued at approximately $464,993.46. This trade represents a 79.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig Barratt sold 1,150 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $510,370.00. Following the completion of the sale, the director owned 1,150 shares of the company’s stock, valued at $510,370. The trade was a 50.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 39,456 shares of company stock valued at $17,769,124 in the last 90 days. 0.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently made changes to their positions in ISRG. Novare Capital Management LLC purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $200,000. Ingalls & Snyder LLC grew its stake in shares of Intuitive Surgical by 3.4% in the third quarter. Ingalls & Snyder LLC now owns 7,817 shares of the medical equipment provider’s stock worth $3,179,000 after acquiring an additional 255 shares during the period. Quantum Capital Management LLC NJ purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $8,129,000. AlphaGrep UK Ltd increased its position in Intuitive Surgical by 33.6% during the third quarter. AlphaGrep UK Ltd now owns 1,256 shares of the medical equipment provider’s stock valued at $511,000 after acquiring an additional 316 shares during the last quarter. Finally, Meeder Advisory Services Inc. increased its position in shares of Intuitive Surgical by 9.3% during the 3rd quarter. Meeder Advisory Services Inc. now owns 8,877 shares of the medical equipment provider’s stock valued at $3,610,000 after purchasing an additional 757 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG opened at $439.89 on Friday. The firm has a market cap of $152.48 billion, a PE ratio of 53.19, a PEG ratio of 3.10 and a beta of 1.45. The stock’s fifty day moving average price is $416.12 and its two-hundred day moving average price is $430.38. Intuitive Surgical has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.40 EPS. Sell-side analysts anticipate that Intuitive Surgical will post 9.37 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.